Pancreatic cancer in Australia: is not it time we address the inequitable resource problem?

Papers of special note have been highlighted as: • of interest

References

• 1. Australian Institute of Health and Welfare. Australia's Health 2018, Chapter 3.4: Cancer (2018). www.aihw.gov.au/getmedia/7beca2c1-b0dd-40b5-ad2b-cf4dfc6a4796/aihw-aus-221-chapter-3-4.pdf.aspx
  Google Scholar
• 2. Drouillard A, Manfredi S, Lepage C, Bouvier AM. [Epidemiology of pancreatic cancer]. Bull. Cancer 105(1), 63–69 (2018).
  MedlineGoogle Scholar
• 3. Pancreatic Cancer in Australia Statistics (2020). https://pancreatic-cancer.canceraustralia.gov.au/statistics
  Google Scholar
• 4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018). • an important resource that provides the most updated global cancer statistics.
  MedlineGoogle Scholar
• 5. Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 55(9–10), 1158–1160 (2016).
  Medline CASGoogle Scholar
• 6. Burmeister EA, O'Connell DL, Beesley VL et al. Describing patterns of care in pancreatic cancer: a population-based study. Pancreas 44(8), 1259–1265 (2015).
  MedlineGoogle Scholar
• 7. Windsor JA, Barreto SG. The concept of ‘borderline resectable’ pancreatic cancer: limited foundations and limited future? J. Gastrointest. Oncol. 8(1), 189–193 (2017).
  MedlineGoogle Scholar
• 8. Barreto S, Windsor J. Justifying vein resection with pancreatoduodenectomy. Lancet Oncol. 17(3), e118–e124 (2016).
  MedlineGoogle Scholar
• 9. Queensland Government. Pancreaticoduodenectomy in Queensland Public and Private Hospitals 2004–2013. Queensland Health, Brisbane, Australia (2015).
  Google Scholar
• 10. Seufferlein T, Hammel P, Delpero JR et al. Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: expert opinion based on a review of current evidence. Cancer Treat. Rev. 77, 1–10 (2019).
  MedlineGoogle Scholar
• 11. Bateni SB, Gingrich AA, Hoch JS, Canter RJ, Bold RJ. Defining value for pancreatic surgery in early-stage pancreatic cancer. JAMA Surg e193019 (2019).
  MedlineGoogle Scholar
• 12. Valle JW, Palmer D, Jackson R et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J. Clin. Oncol. 32(6), 504–512 (2014).
  MedlineGoogle Scholar
• 13. Howard TJ, Krug JE, Yu J et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J. Gastrointest. Surg. 10(10), 1338–1345 (2006).
  MedlineGoogle Scholar
• 14. Shrikhande S, Barreto S, Somashekar B et al. Evolution of pancreatoduodenectomy in a tertiary cancer center in India: improved results from service reconfiguration. Pancreatology 13, 63–71 (2013).
  MedlineGoogle Scholar
• 15. Petty JK, Vetto JT. Beyond doughnuts: tumor board recommendations influence patient care. J. Cancer Educ. 17(2), 97–100 (2002).
  MedlineGoogle Scholar
• 16. Nienhuijs SW, Rutten HJ, Luiten EJ et al. Reduction of in-hospital mortality following regionalisation of pancreatic surgery in the south-east of the Netherlands. Eur. J. Surg. Oncol. 36(7), 652–656 (2010).
  Medline CASGoogle Scholar
• 17. Queensland Government. Chapter 6 Pancreaticoduodenectomy. In: Cancer Surgery in Queensland: Infocus – Access Flows for Public and Private Patients 2002–2011. Queensland Health, Brisbane, Australia (2015).
  Google Scholar
• 18. ABS. Regional Population Growth, Australia 2007–2017 Cat. No 3218.0. (2018).
  Google Scholar
• 19. Fox P, Boyce A. Cancer health inequality persists in regional and remote Australia. Med. J. Aust. 201(8), 445–446 (2014).
  MedlineGoogle Scholar
• 20. Beesley VL, Wockner LF, O'Rourke P et al. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Support. Care Cancer 24(8), 3589–3599 (2016).
  MedlineGoogle Scholar
• 21. Burmeister EA, O'Connell DL, Jordan SJ et al. Factors associated with quality of care for patients with pancreatic cancer in Australia. Med. J. Aust. 205(10), 459–465 (2016).
  MedlineGoogle Scholar
• 22. Burmeister EA, Waterhouse M, Jordan SJ et al. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study. Pancreatology 16(5), 873–881 (2016).
  Medline CASGoogle Scholar
• 23. Creighton N, Walton R, Roder DM et al. Pancreatectomy is underused in NSW regions with low institutional surgical volumes: a population data linkage study. Med. J. Aust. 206(1), 23–29 (2017).
  MedlineGoogle Scholar
• 24. Dumbrava MI, Burmeister EA, Wyld D et al. Chemotherapy in patients with unresected pancreatic cancer in Australia: a population-based study of uptake and survival. Asia Pac. J. Clin. Oncol. 14(4), 326–336 (2018).
  MedlineGoogle Scholar
• 25. Martin HL, Ohara K, Chin W et al. Cancer services in Western Australia: a comparison of regional outcomes with metropolitan Perth. Aust. J. Rural Health 23(5), 302–308 (2015).
  MedlineGoogle Scholar
• 26. Waterhouse MA, Burmeister EA, O'Connell DL et al. Determinants of outcomes following resection for pancreatic cancer: a population-based study. J. Gastrointest. Surg. 20(8), 1471–1481 (2016).
  MedlineGoogle Scholar
• 27. Davis SS, Babidge WJ, Kiermeier A, Maddern GJ. Regional versus metropolitan pancreaticoduodenectomy mortality in Australia. ANZ J. Surg. 89(12), 1582–1586 (2019).
  MedlineGoogle Scholar
• 28. Burmeister EA, Jordan SJ, O'Connell DL et al. Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia Pac. J. Clin. Oncol. 12(2), 105–114 (2016).
  MedlineGoogle Scholar
• 29. Barreto SG, Pandanaboyana S, Ironside N, Windsor JA. Does revision of resection margins based on frozen section improve overall survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma? A meta-analysis. HPB 19(7), 573–579 (2017).
  Google Scholar
• 30. Suker M, Beumer BR, Sadot E et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 17(6), 801–810 (2016).
  Medline CASGoogle Scholar
• 31. Barreto SG, Windsor JA. Justifying vein resection with pancreatoduodenectomy: author’s reply. Lancet Oncol. 17(5), e178 (2016).
  MedlineGoogle Scholar
• 32. Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy 119(4), 464–474 (2015).
  MedlineGoogle Scholar
• 33. Katz MH, Wang H, Fleming JB et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann. Surg. Oncol. 16(4), 836–847 (2009).
  MedlineGoogle Scholar
• 34. Huang L, Jansen L, Balavarca Y et al. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut 68(1), 130–139 (2019).
  MedlineGoogle Scholar
• 35. Hata T, Motoi F, Ishida M et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy: a systematic review and meta-analysis. Ann. Surg. 263(4), 664–672 (2016).
  MedlineGoogle Scholar
• 36. Shukla PJ, Barreto SG, Bedi M et al. Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study. HPB (Oxford) 11(8), 638–644 (2009).
  MedlineGoogle Scholar
• 37. Shrikhande SV, Barreto G, Shukla PJ. Pancreatic fistula after pancreaticoduodenectomy: the impact of a standardized technique of pancreaticojejunostomy. Langenbecks Arch. Surg. 393(1), 87–91 (2008).
  MedlineGoogle Scholar
• 38. Chaudhary A, Barreto S, Talole S, Singh A, Perwaiz A, Singh T. Early discharge after pancreatoduodenectomy: what helps and what prevents? Pancreas 44, 273–278 (2015).
  MedlineGoogle Scholar
• 39. Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med. Care 49(12), 1076–1081 (2011).
  MedlineGoogle Scholar
• 40. Nymo LS, Soreide K, Kleive D, Olsen F, Lassen K. The effect of centralization on short term outcomes of pancreatoduodenectomy in a universal health care system. HPB (Oxford) 21(3), 319–327 (2019).
  MedlineGoogle Scholar
• 41. Soreide K, Nymo LS, Kleive D, Olsen F, Lassen K. Variation in use of open and laparoscopic distal pancreatectomy and associated outcome metrics in a universal health care system. Pancreatology 19(6), 880–887 (2019).
  MedlineGoogle Scholar
• 42. Coory MD, Ho T, Jordan SJ. Australia is continuing to make progress against cancer, but the regional and remote disadvantage remains. Med. J. Aust. 199(9), 605–608 (2013).
  MedlineGoogle Scholar
• 43. Latenstein AEJ, van der Geest LGM, Bonsing BA et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur. J. Cancer 125, 83–93 (2020).
  Medline CASGoogle Scholar
• 44. Farges O, Bendersky N, Truant S, Delpero JR, Pruvot FR, Sauvanet A. The theory and practice of pancreatic surgery in France. Ann. Surg. 266(5), 797–804 (2017).
  MedlineGoogle Scholar
• 45. Klaiber U, Hackert T, Neoptolemos JP. Adjuvant treatment for pancreatic cancer. Transl. Gastroenterol. Hepatol. 4, 27 (2019).
  MedlineGoogle Scholar
• 46. Barreto S. Pancreatic cancer. In: Surgery of the Pancreas and Biliary Tree. Barreto SGWindsor John Albert (Eds). Springer Nature, Singapore (2018).
  Google Scholar
• 47. Clinical Oncological Society of Australia. Mapping rural and regional oncology services in Australia (2006). www.cosa.org.au/publications/reports-and-papers/
  Google Scholar
• 48. Aghdam MRF, Vodovnik A, Hameed RA. Role of telemedicine in multidisciplinary team meetings. J. Pathol. Inform. 10, 35 (2019).
  MedlineGoogle Scholar
• 49. Janssen A, Brunner M, Keep M et al. Interdisciplinary eHealth practice in cancer care: a review of the literature. Int. J. Environ. Res. Public Health 14(11), 1289 (2017).
  Google Scholar
• 50. Sabesan S, Larkins S, Evans R et al. Telemedicine for rural cancer care in North Queensland: bringing cancer care home. Aust. J. Rural Health 20(5), 259–264 (2012).
  MedlineGoogle Scholar
• 51. Thaker DA, Monypenny R, Olver I, Sabesan S. Cost savings from a telemedicine model of care in northern Queensland, Australia. Med. J. Aust. 199(6), 414–417 (2013).
  MedlineGoogle Scholar
• 52. Thobie A, Mulliri A, Dolet N et al. Socioeconomic status impacts survival and access to resection in pancreatic adenocarcinoma: a high-resolution population-based cancer registry study. Surg. Oncol. 27(4), 759–766 (2018).
  MedlineGoogle Scholar
• 53. Briggs DS. Challenges for health systems: Australian perspectives. Public Administration and Policy 20(1), 6–17 (2017).
  Google Scholar
• 54. Macri J. Australia’s health system: some issues and challenges. J. Health Med. Econ. 2, 2 (2016).
  Google Scholar
• 55. Dixit SK, Sambasivan M. A review of the Australian healthcare system: a policy perspective. SAGE Open Med. 6, (2018).
  MedlineGoogle Scholar